According to previous studies, the overexpression of erythropoietin-producing hepatocellular receptor A2 (EphA2) could facilitate carcinogenic effects in various tumors (35); furthermore, EphA2 overexpression has been detected, which is associated with poor prognosis in ESCC (36). Here, EPHA2 is linked to esophageal squamous cell carcinoma.